[Percutaneous Aortic Valve Implantation: What Should We Know?]

Area of Science:

• Interventional Cardiology
• Cardiovascular Medicine
• Medical Technology

Background:

• Severe aortic stenosis (AS) poses significant risks for patients.
• Transcatheter aortic valve implantation (TAVI) emerged in 2002 as a groundbreaking treatment.
• TAVI offers a minimally invasive option for inoperable patients.

Purpose of the Study:

• To provide a comprehensive review of current literature on AS and TAVI.
• To discuss the historical context, diagnosis, and management of AS.
• To explore TAVI devices, techniques, patient selection, and complications.

Main Methods:

• Narrative review of existing studies and literature.
• Analysis of historical data, prevalence, and diagnostic methods for AS.
• Evaluation of current TAVI devices, procedural considerations, and evidence-based outcomes.

Main Results:

• Extensive evidence supports TAVI across various scenarios, showing significant growth.
• Echocardiogram is the primary diagnostic tool for AS, supplemented by other imaging.
• Successful TAVI relies on meticulous patient assessment, appropriate device selection, and experienced teams.

Conclusions:

• TAVI has evolved into a safe and effective minimally invasive procedure.
• It serves as a vital alternative to traditional surgical valve replacement.
• 22 years post-inception, TAVI has transformed aortic stenosis management.